Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis

In Vivo. 2007 Sep-Oct;21(5):745-50.

Abstract

Background: The tumor suppressor protein p16 plays a vital role in the regulation of the cell cycle. The expression of p16 was investigated in an experimental model of chemically induced carcinogenesis in normal and diabetic (type I) Sprague-Dawley rats.

Materials and methods: Tissue sections ranging from normal oral mucosa to moderately differentiated oral squamous cell carcinoma (OSCC) were studied immunohistochemically.

Results: In normal rats p16 expression increased gradually during oral oncogenesis, but a significant increase was observed only in moderately differentiated OSCC (p=0.038). On the contrary, in diabetic rats the detected gradual increase was significant in hyperplasia, dysplasia, early invasion and well-differentiated OSCC (p<0.001). Nevertheless, there was no significant difference in p16 expression during oral oncogenesis between normal and diabetic animals.

Conclusion: It seems that the expression of cell cycle regulator p16 is not affected by diabetes in the studied animal model of oral oncogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Differentiation
  • Cell Transformation, Neoplastic / pathology
  • Cyclin-Dependent Kinase Inhibitor p16 / metabolism*
  • Diabetes Mellitus / metabolism*
  • Diabetes Mellitus / pathology*
  • Female
  • Gene Expression
  • Immunohistochemistry
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology*
  • Neoplasm Invasiveness
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Cyclin-Dependent Kinase Inhibitor p16